Peter  Barrett net worth and biography

Peter Barrett Biography and Net Worth

Director of Revvity

Mr. Barrett joined Atlas Venture, an early stage life sciences venture capital fund, in 2002 and is a partner in the life sciences group. Previously, he was a co-founder, Executive Vice President and Chief Business Officer of Celera Genomics. Prior to that, Mr. Barrett held several senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development. He currently serves as the Chairman of Synlogic, Inc., and as a board member of Larimar Therapeutics and several privately held companies. Mr. Barrett is also a senior fellow at the Harvard Business School.

Mr. Barrett received his Bachelor of Science degree in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Doctoral degree in analytical chemistry from Northeastern University.

Mr. Barrett brings to the board more than three decades of experience in the life sciences industry, including leadership positions both as a senior executive and as an institutional investor. These roles have allowed him to develop expertise in the deployment of strategic growth initiatives within the industry. His service as chair and as a member of the boards of other companies, both publicly and privately held, enables him to assist our board in the performance of its governance obligations.

What is Peter Barrett's net worth?

The estimated net worth of Peter Barrett is at least $0.00 as of May 28th, 2020. Mr. Barrett owns 29,552 shares of Revvity stock worth more than $0 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Barrett may own. Learn More about Peter Barrett's net worth.

How do I contact Peter Barrett?

The corporate mailing address for Mr. Barrett and other Revvity executives is 940 WINTER STREET, WALTHAM MA, 02451. Revvity can also be reached via phone at (781) 663-6900 and via email at [email protected]. Learn More on Peter Barrett's contact information.

Has Peter Barrett been buying or selling shares of Revvity?

Peter Barrett has not been actively trading shares of Revvity in the last ninety days. Most recently, Peter Barrett sold 7,552 shares of the business's stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $100.11, for a transaction totalling $756,030.72. Following the completion of the sale, the director now directly owns 29,552 shares of the company's stock, valued at $2,958,450.72. Learn More on Peter Barrett's trading history.

Who are Revvity's active insiders?

Revvity's insider roster includes Peter Barrett (Director), Joel Goldberg (Insider), Sylvie Gregoire (Director), Maxwell Krakowiak (Insider), James Mock (Insider), Andrew Okun (Insider), Prahlad Singh (Insider), Daniel Tereau (Insider), and Tajinder Vohra (Insider). Learn More on Revvity's active insiders.

Peter Barrett Insider Trading History at Revvity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/28/2020Sell7,552$100.11$756,030.7229,552View SEC Filing Icon  
2/13/2019Sell5,601$93.62$524,365.6227,630View SEC Filing Icon  
11/13/2017Sell7,071$71.07$502,535.9726,271View SEC Filing Icon  
6/1/2017Sell10,000$63.22$632,200.0029,200View SEC Filing Icon  
See Full Table

Peter Barrett Buying and Selling Activity at Revvity

This chart shows Peter Barrett's buying and selling at Revvity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Revvity Company Overview

Revvity logo
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $127.73
Low: $115.24
High: $137.11

2 Week Range

Now: N/A

Volume

1,633,000 shs

Average Volume

851,117 shs

Market Capitalization

$14.57 billion

P/E Ratio

15.01

Dividend Yield

0.24%

Beta

1.1